Approval · Notice of Compliance 16963 · 2015
VERELAN: Notice of Compliance 16963
Issued June 3, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16963
- Date
- June 3, 2015
- Company
- Recro Gainesville LlcGainesville, Georgia, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Merger - buyout
- Therapeutic class
- Antihypertensive agent
Products in this notice
Medicinal ingredients
- VERAPAMIL HCL 120 MG per CAP
- VERAPAMIL HCL 180 MG per CAP
- VERAPAMIL HCL 240 MG per CAP